Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

EXEL

Exelixis Inc

May 02 • 04:00PM ET

22.12

Dollar change +0.20
Percentage change 0.89	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IJH VB VXF VBK IBB IJK FBT SCHA VHT

Index	-	P/E	34.21	EPS (ttm)	0.65	Insider Own	2.76%	Shs Outstand	302.79M	Perf Week	-5.99%
Market Cap	6.52B	Forward P/E	14.57	EPS next Y	1.52	Insider Trans	-0.19%	Shs Float	286.65M	Perf Month	-6.63%
Income	205.05M	PEG	1.80	EPS next Q	0.31	Inst Own	89.10%	Short Float	3.01%	Perf Quarter	1.70%
Sales	1.85B	P/S	3.53	EPS this Y	81.92%	Inst Trans	-2.01%	Short Ratio	3.70	Perf Half Y	7.43%
Book/sh	7.21	P/B	3.07	EPS next Y	28.41%	ROA	6.90%	Short Interest	8.62M	Perf Year	17.47%
Cash/sh	3.27	P/C	6.77	EPS next 5Y	19.00%	ROE	8.76%	52W Range	18.52 - 24.34	Perf YTD	-7.79%
Dividend Est.	-	P/FCF	23.32	EPS past 5Y	-21.77%	ROI	8.80%	52W High	-9.12%	Beta	0.59
Dividend TTM	-	Quick Ratio	3.41	Sales past 5Y	17.31%	Gross Margin	95.70%	52W Low	19.44%	ATR (14)	0.66
Dividend Ex-Date	-	Current Ratio	3.46	EPS Y/Y TTM	37.20%	Oper. Margin	11.07%	RSI (14)	39.32	Volatility	2.98% 2.46%
Employees	1310	Debt/Eq	0.09	Sales Y/Y TTM	10.98%	Profit Margin	11.10%	Recom	1.73	Target Price	26.73
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	-0.49%	Payout	0.00%	Rel Volume	1.38	Prev Close	21.92
Sales Surprise	-7.77%	EPS Surprise	-47.04%	Sales Q/Q	4.02%	Earnings	Apr 30 AMC	Avg Volume	2.33M	Price	22.12
SMA20	-4.34%	SMA50	-3.33%	SMA200	0.91%	Trades		Volume	3,206,619	Change	0.89%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-11-24	Downgrade	Barclays	Overweight → Equal Weight	$25
Dec-19-23	Initiated	BTIG Research	Buy	$27
Dec-15-23	Initiated	Citigroup	Buy	$31
Sep-26-23	Initiated	H.C. Wainwright	Buy	$28
Aug-22-23	Reiterated	Oppenheimer	Outperform	$25 → $29
Aug-08-23	Initiated	SVB Securities	Market Perform	$18
Jul-11-23	Resumed	Morgan Stanley	Equal-Weight	$21
May-10-23	Resumed	Piper Sandler	Overweight	$28
Mar-09-23	Initiated	Wells Fargo	Overweight	$23
Jan-26-23	Initiated	Credit Suisse	Outperform	$29
Oct-18-22	Initiated	JMP Securities	Mkt Outperform	$26
Jun-24-22	Initiated	BMO Capital Markets	Outperform	$28
Nov-19-21	Initiated	Piper Sandler	Overweight	$34
Nov-03-21	Resumed	Jefferies	Buy	$28
Oct-07-21	Initiated	Jefferies	Buy	$28
Aug-06-21	Reiterated	H.C. Wainwright	Buy	$35 → $64
Jun-15-21	Initiated	H.C. Wainwright	Buy	$47
May-18-21	Resumed	Goldman	Sell	$23
Mar-31-21	Initiated	Credit Suisse	Outperform	$30
Mar-12-21	Initiated	Wolfe Research	Outperform	$35

Show Previous Ratings

May-02-24 03:33PM	Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 11:15AM	RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept (MT Newswires) -6.54%
09:14AM	Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short (Zacks)
07:39AM	Q1 2024 Exelixis Inc Earnings Call (Thomson Reuters StreetEvents)
03:35AM	Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:00AM	Loading…
12:00AM	Exelixis (EXEL) Q1 2024 Earnings Call Transcript (Motley Fool)
Apr-30-24 08:57PM	EXEL Stock Earnings: Exelixis Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:30PM	Exelixis (EXEL) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:35PM	Exelixis Inc (EXEL) Q1 2024 Earnings: Mixed Results Amidst Restructuring Efforts (GuruFocus.com)
05:26PM	Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Maintained -- Shares Fall After Hours (MT Newswires)
04:19PM	Exelixis: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update (Business Wire)
Apr-27-24 07:00AM	The Top 3 Biotech Stocks to Buy in April 2024 (InvestorPlace)
Apr-16-24 04:05PM	Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024 (Business Wire)
Mar-28-24 08:13AM	Insiders Are Dumping These 10 Healthcare Stocks (Insider Monkey)
05:06AM	Loading…
Mar-23-24 05:06AM	4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market (Motley Fool)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-08-24 09:38AM	10 Biotech Stocks with Huge Potential (Insider Monkey)
08:15AM	2 Biotech Stocks to Buy Hand Over Fist in March (Motley Fool)
Mar-07-24 11:31AM	Why Is Exelixis (EXEL) Up 10.9% Since Last Earnings Report? (Zacks)
10:08AM	10 Mid-Cap Stocks with Insider Purchases (Insider Monkey)
Mar-06-24 04:45PM	3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success (InvestorPlace)
Mar-04-24 07:06PM	Analyst Report: Exelixis, Inc. (Morningstar Research)
Mar-02-24 05:06AM	4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market (Motley Fool)
Feb-27-24 04:05PM	Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March (Business Wire)
08:00AM	Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments (GuruFocus.com)
Feb-26-24 07:42AM	Jumpstart Your Portfolio With These 3 Biotech Stocks (Entrepreneur: Stocks)
Feb-23-24 01:11PM	Hedge Fund and Insider Trading News: Israel Englander, Citadel LLC, Two Sigma Advisors, Bridgewater Associates, Balyasny Asset Management, Exelixis Inc (EXEL), Agree Realty Corporation (ADC), and More (Insider Monkey)
Feb-19-24 08:00AM	2 Stocks Under $30 to Buy and Hold (Motley Fool)
Feb-14-24 08:30AM	Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies (GlobeNewswire)
01:47AM	Loading…
01:47AM	Jim Simons Increases Stake in Exelixis Inc (GuruFocus.com)
Feb-13-24 08:00AM	The 3 Best Biotech Stocks to Buy in February 2024 (InvestorPlace)
Feb-12-24 09:35AM	Exelixis (EXEL) Loses -10.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Feb-10-24 05:06AM	4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip (Motley Fool)
Feb-09-24 09:35AM	Down -10% in 4 Weeks, Here's Why You Should You Buy the Dip in Exelixis (EXEL) (Zacks)
Feb-08-24 06:50PM	Analyst Report: Exelixis, Inc. (Morningstar Research)
09:35AM	Exelixis (EXEL) Loses -11.72% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Feb-07-24 07:01PM	Analyst Report: Exelixis, Inc. (Morningstar Research) -7.56%
01:13PM	Exelixis (EXEL) Q4 Earnings Beat on Lower R&D Spend, Sales Miss (Zacks)
10:47AM	Exelixis, Inc. (NASDAQ:EXEL) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:45AM	Q4 2023 Exelixis Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-06-24 08:45PM	Exelixis (EXEL) Q4 2023 Earnings Call Transcript (Motley Fool)
06:30PM	Exelixis (EXEL) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:25PM	Exelixis (EXEL) Tops Q4 Earnings Estimates (Zacks)
05:01PM	Exelixis Inc (EXEL) Reports Strong Revenue Growth and Expanding Pipeline in Q4 and FY 2023 Earnings (GuruFocus.com)
04:33PM	Exelixis: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update (Business Wire)
Feb-01-24 04:05PM	Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February (Business Wire)
Jan-30-24 10:00AM	Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-29-24 09:40AM	Here's Why Exelixis (EXEL) is a Strong Value Stock (Zacks)
Jan-25-24 08:00AM	Exelixis Announces Detailed Results of Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer Presented at ASCO GU 2024 (Business Wire)
Jan-23-24 04:05PM	Exelixis to Release Fourth Quarter and Fiscal Year 2023 Financial Results on Tuesday, February 6, 2024 (Business Wire)
Jan-22-24 05:00PM	Opdivo (nivolumab) in Combination with CABOMETYX (cabozantinib) Demonstrates Long-Term Survival Benefits After Four Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma (Business Wire)
Jan-21-24 01:16PM	3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024 (InvestorPlace)
Jan-19-24 11:21AM	Exelixis (EXEL) Reports Positive EU Patent Ruling for Cabometyx (Zacks)
Jan-18-24 04:05PM	European Patent Office Rules in Favor of Exelixis on Formulation Patent Covering CABOMETYX (cabozantinib) Tablets (Business Wire)
04:00PM	3 Pharma Stocks Could Be the Pills Your Portfolio Needs (InvestorPlace)
Jan-17-24 11:29AM	Exelixis (EXEL) Outperforms on Cabometyx and Pipeline Progress (Zacks)
Jan-11-24 09:40AM	Why Exelixis (EXEL) is a Top Value Stock for the Long-Term (Zacks)
Jan-08-24 04:40PM	Regeneron Slumps As Its Biggest Moneymaker Flops Amid Ongoing Roche Rivalry (Investor's Business Daily)
12:43PM	Exelixis (EXEL) Posts Preliminary 2023 Results, to Cut 13% Jobs (Zacks)
06:12AM	Exelixis lays off 175 employees in refocus on 'emerging pipeline' (FierceBiotech.com)
Jan-07-24 04:00PM	Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024 (Business Wire)
Jan-02-24 04:05PM	Exelixis to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024 (Business Wire)
Dec-19-23 10:16AM	11 Stocks Insiders and Billionaires Are Crazy About (Insider Monkey)
Dec-12-23 08:54AM	Is the Options Market Predicting a Spike in Exelixis (EXEL) Stock? (Zacks)
Dec-07-23 04:05PM	Exelixis 2023 R&D Day: Science & Strategy to be Webcast on December 12, 2023 (Business Wire)
Dec-05-23 01:51PM	Exelixis (EXEL) Collaborates With Arcus for Kidney Cancer Study (Zacks)
Dec-04-23 07:26PM	Analyst Report: Exelixis, Inc. (Morningstar Research)
08:02AM	Exelixis Announces Initiation of the STELLAR-305 Phase 2/3 Pivotal Trial Evaluating Zanzalintinib in Combination with Pembrolizumab in Patients with Previously Untreated Recurrent or Metastatic Head and Neck Cancer (Business Wire)
08:00AM	Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma (Business Wire)
Dec-01-23 11:32AM	Exelixis (EXEL) Up 8.4% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-29-23 10:45AM	Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment (PR Newswire)
Nov-21-23 04:05PM	Exelixis to Present at the Piper Sandler 35th Annual Healthcare Conference on November 28, 2023 (Business Wire)
Nov-17-23 01:33PM	Exelixis (EXEL) Gains 30% YTD on Cabometyx, Pipeline Progress (Zacks)
Nov-10-23 09:00AM	Exelixis Announces Encouraging Results from Expansion Cohort of Phase 1b STELLAR-001 Trial Evaluating Zanzalintinib in Patients with Advanced Kidney Cancer at IKCS 2023 (Business Wire)
Nov-09-23 04:43PM	Under the Microscope: 3 Biotech Stocks Pioneering Tomorrows Cures (InvestorPlace)
Nov-08-23 05:24PM	3 Biotech Stocks With the Strongest Clinical Pipelines (InvestorPlace)
05:19AM	3 Promising Biotech Stocks Flying Under the Radar (InvestorPlace)
Nov-06-23 09:47AM	Exelixis, Inc. (NASDAQ:EXEL) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 12:11PM	Analyst Report: Exelixis, Inc. (Morningstar Research)
Nov-02-23 11:23AM	Exelixis (EXEL) Q3 Earnings and Sales Miss, Annual View Updated (Zacks)
12:30AM	Exelixis (EXEL) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-01-23 07:00PM	Compared to Estimates, Exelixis (EXEL) Q3 Earnings: A Look at Key Metrics (Zacks)
06:05PM	Exelixis Inc (EXEL) Reports Q3 2023 Earnings: Total Revenues of $471.9 Million (GuruFocus.com)
04:05PM	Exelixis Announces Third Quarter 2023 Financial Results and Provides Corporate Update (Business Wire)
Oct-30-23 10:00AM	My Sights Are Locked on 3 Biotech Plays as the End of the Year Nears (TheStreet.com)
Oct-28-23 05:06AM	4 Dominant Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip (Motley Fool)
Oct-27-23 04:58AM	Strength Seen in Exelixis (EXEL): Can Its 5.6% Jump Turn into More Strength? (Zacks)
Oct-26-23 10:02AM	Analysts Estimate Regeneron (REGN) to Report a Decline in Earnings: What to Look Out for (Zacks) +5.58%
Oct-25-23 10:01AM	Analysts Estimate Exelixis (EXEL) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:30AM	Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030 (PR Newswire)
Oct-22-23 02:30AM	Detailed Results from Phase 3 CABINET Pivotal Trial Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2023 (Business Wire)
Oct-19-23 06:51PM	Analyst Report: Exelixis, Inc. (Morningstar Research)
08:15AM	3 Under-the-Radar Biotech Stocks to Buy in 2023 (Motley Fool)
Oct-18-23 04:05PM	Exelixis to Release Third Quarter 2023 Financial Results on Wednesday, November 1, 2023 (Business Wire)
08:30AM	Is Exelixis Stock a Buy Now? (Motley Fool)
Oct-12-23 11:40AM	EXEL vs. TECH: Which Stock Is the Better Value Option? (Zacks)
Oct-09-23 02:03AM	14 Best Cancer Stocks To Buy Now (Insider Monkey)
Oct-02-23 09:49AM	Steady Eddies: 3 Low Beta Stocks for Long-Haul Gains (InvestorPlace)

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Garber Alan M	Director	Mar 21 '24	Option Exercise	19.57	23,491	459,719	54,908	Mar 25 07:31 PM
Garber Alan M	Director	Mar 21 '24	Sale	24.01	19,205	461,112	35,703	Mar 25 07:31 PM
Haley Patrick J.	EVP, Commercial	Feb 23 '24	Sale	21.45	47,020	1,008,579	384,866	Feb 27 06:58 PM
JOHNSON DAVID EDWARD	Director	Feb 21 '24	Buy	20.70	190,000	3,932,734	1,100,730	Feb 22 05:08 PM
Haley Patrick J.	EVP, Commercial	Dec 14 '23	Option Exercise	16.29	50,000	814,500	357,687	Dec 14 07:56 PM
Haley Patrick J.	EVP, Commercial	Dec 14 '23	Sale	23.35	50,000	1,167,500	307,687	Dec 14 07:56 PM
Hessekiel Jeffrey	EVP, General Counsel & Sec	Dec 13 '23	Sale	23.01	25,000	575,250	533,345	Dec 14 07:55 PM
Haley Patrick J.	EVP, Commercial	Dec 12 '23	Sale	22.50	14,149	318,352	307,687	Dec 14 07:56 PM
Hessekiel Jeffrey	EVP, General Counsel & Sec	Dec 04 '23	Sale	22.06	25,000	551,500	558,345	Dec 04 06:22 PM
Hessekiel Jeffrey	EVP, General Counsel & Sec	Nov 30 '23	Sale	22.01	25,000	550,250	583,345	Dec 04 06:22 PM
JOHNSON DAVID EDWARD	Director	Nov 27 '23	Buy	21.61	120,409	2,602,038	910,730	Nov 29 04:30 PM
JOHNSON DAVID EDWARD	Director	Nov 27 '23	Sale	21.61	120,409	2,602,038	790,321	Nov 29 04:30 PM
Aftab Dana	CSO/EVP Disc & Trans Research	Aug 30 '23	Sale	22.47	4,600	103,362	399,943	Sep 01 08:15 PM
MORRISSEY MICHAEL	President and CEO	Aug 28 '23	Option Exercise	15.31	360,000	5,511,600	945,496	Aug 30 09:48 PM
Senner Christopher J.	EVP and CFO	Aug 04 '23	Option Exercise	14.74	60,000	884,400	631,631	Aug 07 09:20 PM
Senner Christopher J.	EVP and CFO	Aug 04 '23	Sale	20.68	60,000	1,240,800	571,631	Aug 07 09:20 PM
Senner Christopher J.	EVP and CFO	Aug 03 '23	Option Exercise	14.74	60,000	884,400	631,631	Aug 07 09:20 PM
Senner Christopher J.	EVP and CFO	Aug 03 '23	Sale	20.51	60,000	1,230,600	571,631	Aug 07 09:20 PM
Haley Patrick J.	EVP, Commercial	Aug 03 '23	Sale	20.67	30,553	631,531	285,467	Aug 07 08:24 PM
Hessekiel Jeffrey	EVP, General Counsel & Sec	Aug 01 '23	Option Exercise	14.74	55,710	821,165	627,686	Aug 03 08:02 PM
Hessekiel Jeffrey	EVP, General Counsel & Sec	Aug 01 '23	Sale	19.63	55,710	1,093,587	571,976	Aug 03 08:02 PM

Open in Screener

WB

Weibo Corp ADR

May 02 • 04:00PM ET

9.29

Dollar change +0.71
Percentage change 8.28	%

Communication Services • Internet Content & Information • China • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Index	-	P/E	6.49	EPS (ttm)	1.43	Insider Own	0.04%	Shs Outstand	155.49M	Perf Week	10.20%
Market Cap	1.44B	Forward P/E	4.65	EPS next Y	2.00	Insider Trans	0.00%	Shs Float	155.43M	Perf Month	8.23%
Income	342.60M	PEG	1.59	EPS next Q	0.36	Inst Own	47.60%	Short Float	6.91%	Perf Quarter	20.05%
Sales	1.76B	P/S	0.82	EPS this Y	-1.59%	Inst Trans	-5.71%	Short Ratio	4.25	Perf Half Y	-13.54%
Book/sh	21.96	P/B	0.42	EPS next Y	8.09%	ROA	4.76%	Short Interest	10.74M	Perf Year	-32.38%
Cash/sh	20.93	P/C	0.44	EPS next 5Y	4.08%	ROE	10.18%	52W Range	7.12 - 15.09	Perf YTD	-6.59%
Dividend Est.	0.40 (4.29%)	P/FCF	-	EPS past 5Y	-10.97%	ROI	6.47%	52W High	-38.43%	Beta	0.23
Dividend TTM	-	Quick Ratio	2.51	Sales past 5Y	1.84%	Gross Margin	78.73%	52W Low	30.46%	ATR (14)	0.38
Dividend Ex-Date	Apr 11, 2024	Current Ratio	2.51	EPS Y/Y TTM	296.59%	Oper. Margin	26.87%	RSI (14)	65.44	Volatility	3.50% 4.01%
Employees	5268	Debt/Eq	0.80	Sales Y/Y TTM	-4.17%	Profit Margin	19.47%	Recom	2.08	Target Price	12.17
Option/Short	Yes / Yes	LT Debt/Eq	0.56	EPS Q/Q	-42.77%	Payout	0.00%	Rel Volume	0.96	Prev Close	8.58
Sales Surprise	1.45%	EPS Surprise	-38.43%	Sales Q/Q	3.50%	Earnings	Mar 14 BMO	Avg Volume	2.52M	Price	9.29
SMA20	13.61%	SMA50	12.07%	SMA200	-6.13%	Trades		Volume	2,419,633	Change	8.28%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-28-24	Downgrade	Goldman	Buy → Neutral
Mar-19-24	Upgrade	UBS	Neutral → Buy	$11.50
Jan-11-24	Downgrade	BofA Securities	Buy → Underperform	$19.50 → $10
Aug-25-23	Downgrade	The Benchmark Company	Buy → Hold
Jun-13-23	Downgrade	UBS	Buy → Neutral	$33 → $15.50
Jan-30-23	Initiated	JP Morgan	Neutral
Jan-09-23	Upgrade	Goldman	Neutral → Buy	$25
Apr-11-22	Resumed	Goldman	Neutral	$37.50
Mar-11-22	Downgrade	UBS	Buy → Neutral	$64 → $27.80
Aug-19-21	Upgrade	Credit Suisse	Neutral → Outperform	$48 → $56
Sep-29-20	Upgrade	CLSA	Outperform → Buy
Apr-22-20	Downgrade	Barclays	Overweight → Equal Weight	$47 → $40
Nov-15-19	Downgrade	CLSA	Buy → Outperform
Nov-14-19	Downgrade	Credit Suisse	Outperform → Neutral
Oct-18-19	Upgrade	Jefferies	Hold → Buy
Oct-04-19	Upgrade	Credit Suisse	Neutral → Outperform
Aug-19-19	Upgrade	CLSA	Outperform → Buy
Aug-05-19	Initiated	Jefferies	Hold
May-28-19	Downgrade	JP Morgan	Overweight → Neutral
May-24-19	Reiterated	The Benchmark Company	Buy	$81 → $51

Show Previous Ratings

Apr-30-24 10:18AM	iPhone 16 may come in new color-infused green (AppleInsider)
Apr-25-24 06:13AM	Weibo Files its Annual Report on Form 20-F (PR Newswire)
Apr-19-24 04:04AM	Weibo Publishes 2023 Environmental, Social and Governance Report (PR Newswire)
Apr-17-24 05:48PM	The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback (InvestorPlace)
Apr-14-24 12:06AM	25 Biggest Social Media Companies and Platforms for Advertisers (Insider Monkey)
11:09AM	Loading…
Apr-12-24 11:09AM	10 Most Undervalued Stocks to Buy for Under $20 (Insider Monkey) -6.95%
Apr-08-24 05:45AM	Weibo to Hold Annual General Meeting on May 22, 2024 (PR Newswire)
Apr-01-24 03:32PM	36Kr Holdings Inc. (NASDAQ:KRKR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-31-24 10:24PM	INSIGHT-Chinese state media stoked allegation Taiwan's president would flee war (Reuters)
Mar-27-24 06:52AM	Q4 2023 Ryvyl Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-22-24 07:07AM	Netflix's '3 Body Problem' leaves jaws dropped among Chinese viewers (Reuters) -5.18%
Mar-19-24 11:55PM	Apple boss Tim Cook visits Shanghai with China sales under pressure (Reuters)
11:42PM	Apple boss Tim Cook visiting Shanghai (Reuters)
Mar-14-24 09:30AM	Here's What Key Metrics Tell Us About Weibo Corporation (WB) Q4 Earnings (Zacks)
05:00AM	Weibo Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results and Dividend (PR Newswire)
11:29PM	Loading…
Mar-12-24 11:29PM	UPDATE 3-Devastating blast in China's Hebei kills two, injures 26 (Reuters)
07:43AM	5 Things to Know Before the Stock Market Opens (Investopedia)
Mar-11-24 09:55PM	China's Xiaomi to start first EV deliveries this month (Reuters)
Feb-27-24 04:00AM	Weibo Corporation to Report Fourth Quarter and Fiscal Year 2023 Financial Results on March 14, 2024 (PR Newswire)
Feb-23-24 05:27PM	Exit Now! 3 Social Media Stocks to Sell in February 2024 (InvestorPlace)
04:30AM	Russia makes its case to China social media users ahead of Ukraine war anniversary (South China Morning Post)
Feb-20-24 02:38AM	Pork flavored coffee is Starbucks newest China pitch (CNN Business)
Feb-11-24 06:23AM	3 Sorry Social Media Stocks to Sell in February While You Still Can (InvestorPlace)
Feb-04-24 04:03AM	Chinese turn U.S. embassy post into 'Wailing Wall' for stock plunge (Reuters)
Jan-04-24 04:30AM	Beijing calls for halt to Myanmar fighting after stray artillery fire injured five in Chinese border town (South China Morning Post)
Dec-21-23 04:30AM	Elon Musk's X becomes top trending topic on China's Weibo after outage, taking many netizens by surprise (South China Morning Post)
01:32AM	UPDATE 1-A dozen still missing after China's earthquake, 137 dead (Reuters)
Dec-20-23 09:14PM	A dozen still missing after China's earthquake (Reuters)
Dec-18-23 08:36AM	Are Options Traders Betting on a Big Move in Weibo (WB) Stock? (Zacks)
Dec-14-23 11:18PM	Chinas Weibo Asks Bloggers to Avoid Badmouthing the Economy (Bloomberg)
08:56AM	Loading…
Nov-30-23 08:56AM	Weibo Corporation Prices Offering of American Depositary Shares in connection with the Delta Placement of Borrowed ADSs (PR Newswire) -10.69%
08:55AM	Weibo Corporation Prices Offering of US$300 Million Convertible Senior Notes (PR Newswire)
Nov-29-23 04:21PM	Weibo Corporation Announces Proposed Offering of American Depositary Shares in connection with the Delta Placement of Borrowed ADSs (PR Newswire)
04:19PM	Weibo Corporation Announces Proposed Offering of US$300 Million Convertible Senior Notes (PR Newswire)
Nov-27-23 11:16AM	UPDATE 1-China's Didi Global says ride-hailing app had 'systems malfunction' (Reuters)
02:05AM	Beijing frets over Taiwan opposition split as parties go on the attack over China ties (Reuters)
Nov-13-23 07:11PM	11 Cheap Chinese Stocks to Buy Right Now (Insider Monkey)
Nov-10-23 02:48PM	Weibo Corporation (NASDAQ:WB) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 09:30AM	Weibo Corporation (WB) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) -5.72%
04:00AM	Weibo Reports Third Quarter 2023 Unaudited Financial Results (PR Newswire)
Nov-02-23 02:46AM	Blackpinks Lisa, Angelababy Banned on Weibo After Risque Show (Bloomberg)
Nov-01-23 05:30AM	Chinese social media platforms Weibo, WeChat and Douyin's real-name authentication rule for influencers to benefit operations amid tightened online regulation, analysts say (South China Morning Post)
Oct-31-23 06:48PM	Leaker corroborates iPhone 16 capacitive capture button rumor (AppleInsider)
08:20AM	UPDATE 1-China removes anonymity of bloggers' accounts with more than 500,000 followers (Reuters)
07:11AM	Tencent, Kuaishou Demand Real Names in China Internet Tightening (Bloomberg)
Oct-27-23 12:23AM	The sudden death of China's former No. 2 leader Li Keqiang has shocked many (Associated Press Finance)
Oct-26-23 09:40AM	Should Value Investors Buy DHI Group (DHX) Stock? (Zacks)
Oct-25-23 11:40AM	WB vs. ABNB: Which Stock Is the Better Value Option? (Zacks)
09:55AM	Wall Street Analysts Think Weibo Corporation (WB) Could Surge 54.47%: Read This Before Placing a Bet (Zacks)
05:00AM	Weibo Corporation to Report Third Quarter 2023 Financial Results on November 9, 2023 (PR Newswire)
Oct-24-23 12:44AM	Chinas X-Like Service Asks Top Influencers to Show Real Names (Bloomberg) +6.09%
Oct-20-23 06:18AM	CEO of China's Weibo tests new real-name policy on his own account (Reuters)
Oct-05-23 12:01PM	5 Leading Social Media Companies In The Artificial Intelligence Theme (Insider Monkey)
Sep-30-23 10:50AM	China's lottery ticket sales soar amid weak economy, job prospects (Reuters)
Sep-22-23 12:35PM	Is Weibo (WB) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
Sep-07-23 05:30AM	China crypto crackdown: Weibo banishes 80 prominent cryptocurrency influencers (South China Morning Post) -5.72%
Aug-25-23 11:48AM	Is Weibo Corp (WB) a Hidden Value Trap? Unpacking the Risks and Rewards (GuruFocus.com) -8.83%
09:39AM	Weibo Corporation (NASDAQ:WB) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-24-23 05:15AM	Weibo Reports Second Quarter 2023 Unaudited Financial Results (PR Newswire)
Aug-18-23 04:36AM	The Voice of China Producer Falls by Record After Viral Video (Bloomberg)
Aug-09-23 05:00AM	Weibo Corporation to Report Second Quarter 2023 Financial Results on August 24, 2023 (PR Newswire)
Aug-08-23 04:20PM	Paramount earnings: Streamers' growth is 'certainly slowing,' analyst explains (Yahoo Finance Video)
Aug-01-23 11:54PM	Rescuers focus on flooded city south of Beijing after historic rains in north China (Reuters)
Jun-26-23 10:09PM	China Bans Negative Finance Writers as Stock Market Sinks (Bloomberg)
Jun-23-23 02:54PM	10 Stocks that Paid Special Dividends in 2023 (Insider Monkey)
May-25-23 05:00AM	Weibo Reports First Quarter 2023 Unaudited Financial Results and Dividend (PR Newswire)
May-24-23 04:30AM	Weibo Announces Results of 2023 Annual General Meeting (PR Newswire)
May-10-23 09:40AM	Is Perion Network (PERI) Stock Undervalued Right Now? (Zacks)
May-05-23 05:00AM	Weibo Corporation to Report First Quarter 2023 Financial Results on May 25, 2023 (PR Newswire)
May-01-23 11:40AM	WB vs. RELX: Which Stock Should Value Investors Buy Now? (Zacks)
Apr-27-23 05:30AM	Weibo Files its Annual Report on Form 20-F (PR Newswire)
Apr-21-23 06:43AM	BMW apologizes for its slipup at Shanghai auto show, after social media users accuse it of giving ice cream to foreigners and not locals (Fortune)
Apr-20-23 01:59AM	BMW skids into ice cream melee at Shanghai auto show (Reuters)
Apr-14-23 11:40AM	WB or SSTK: Which Is the Better Value Stock Right Now? (Zacks)
Apr-03-23 05:30AM	Weibo to Hold Annual General Meeting on May 24, 2023 (PR Newswire) -5.18%
Mar-31-23 05:30AM	Apple CEO Tim Cook's whistle-stop tour of Shanghai bolsters ties with Genshin impact creator miHoYo, other local app developers (South China Morning Post)
Mar-29-23 11:40AM	WB vs. ABNB: Which Stock Is the Better Value Option? (Zacks)
Mar-22-23 10:04AM	Implied Volatility Surging for Weibo (WB) Stock Options (Zacks)
Mar-21-23 11:45AM	U.S. State-Government Websites Use TikTok Trackers, Review Finds (The Wall Street Journal)
11:45AM	State-Government Websites Use TikTok Trackers, Review Finds (The Wall Street Journal)
10:00AM	TikTok Trackers Embedded in U.S. State-Government Websites, Review Finds (The Wall Street Journal)
Mar-06-23 10:13PM	Weibo Corporation (NASDAQ:WB) Q4 2022 Earnings Call Transcript (Insider Monkey)
04:30AM	China's social media sounds the alarm bell about India's development as Apple's next hub for iPhone manufacturing supply chain (South China Morning Post)
Mar-02-23 04:30AM	Beijing proxies voice support for TikTok as the ByteDance-owned video app faces bans in US, EU (South China Morning Post)
Mar-01-23 07:29AM	Weibo Q4 Highlights: 27% Revenue Decline, Margin Contraction Due To China's COVID Measures (Benzinga) -7.54%
04:45AM	Weibo Reports Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results (PR Newswire)
Feb-28-23 08:36AM	Is a Surprise Coming for Weibo (WB) This Earnings Season? (Zacks)
08:00AM	RESAAS Enables Real Estate Agents to Market Across Asia Using Sina Weibo, a Leading Social Media Platform in Asia (PR Newswire)
Feb-21-23 04:00PM	Tencent Becomes a Cant-Touch Stock for Some ESG Investors (Bloomberg)
Feb-15-23 04:00AM	Weibo Corporation to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023 (PR Newswire)
Jan-27-23 09:36AM	Weibo and Viasat have been highlighted as Zacks Bull and Bear of the Day (Zacks)
08:57AM	Weibo Corporation (WB) Surges 14.0%: Is This an Indication of Further Gains? (Zacks)
06:00AM	Bull of the Day: Weibo Corp. (WB) (Zacks)
Jan-23-23 11:40AM	WB vs. RELX: Which Stock Is the Better Value Option? (Zacks)
Dec-31-22 02:44AM	WRAPUP 1-China censors COVID-related content online as New Year's Eve prompts reflection by some (Reuters)
Dec-27-22 01:21PM	China stocks tell 2 different stories about the economy (Yahoo Finance) +8.82%
Dec-26-22 08:46PM	Weibo Corporation (NASDAQ:WB) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-21-22 11:35AM	Elon Musk posts cryptic message to Chinese social media site Weibo as he confirms Twitter exit plan (Fox Business)
Dec-14-22 01:19AM	Medical staff in China's hospitals say COVID-19 ripping through their ranks (Reuters)
Dec-13-22 01:10AM	Blizzard talking with potential partners to continue offering World of Warcraft in China (Reuters)

Weibo Corp. engages in the creation, distribution, and discovery of Chinese-language content. It operates through the Advertising and Marketing Services, and Other Services segments. The company was founded in August 2009 and is headquartered in Beijing, China.

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

EXEL

Exelixis Inc

WB

Weibo Corp ADR

Upgrade your FINVIZ experience